Dataset from Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies. Int J Nanomedicine. 2012;7:5793-806 (v.0)

This dataset includes data on the formulation of CB13-loaded nanoparticles, characterization results (size, zeta potential, and encapsulation efficiency), in vitro drug release profiles, cytotoxicity assays, and stability studies. This dataset provides detailed insights into how PLGA nanocarriers ca...

ver descrição completa

Detalhes bibliográficos
Autores: Durán Lobato, María Matilde, Álvarez Fuentes, Josefa, Martín Banderas, Lucía, Prados Salazar, José Carlos, Melguizo Alonso, Consolación, Fernández Arévalo, María Mercedes, Holgado Villafuerte, María Ángeles
Tipo de documento: conjunto de datos
Data de publicação:2024
País:España
Recursos:Universidad de Sevilla (US)
Repositório:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/166308
Acesso em linha:https://hdl.handle.net/11441/166308
https://doi.org/10.12795/11441/166308
Access Level:Acceso aberto
Palavra-chave:Dolor neuropático
CB13
Nanoprecipitación
Neuropathic pain
Nanoprecipitation
Descrição
Resumo:This dataset includes data on the formulation of CB13-loaded nanoparticles, characterization results (size, zeta potential, and encapsulation efficiency), in vitro drug release profiles, cytotoxicity assays, and stability studies. This dataset provides detailed insights into how PLGA nanocarriers can improve the oral bioavailability of hydrophobic drugs like CB13, with pharmacological potential in pathologies such as neuropathic pain.

Registros relacionados